Lanping Jiang
Appearances
- DateMay 8, 2023BACKGROUND: Through shotgun metagenomic sequencing, we identified the depletion of probiotic species_ Lactobacillus acidophilus_ in stools of mice with non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC)…
Presenter
Speakers
The Chinese University of Hong Kong - DateMay 20, 2024BACKGROUND: _Clostridium butyricum_ is a known probiotic bacterium with anti-inflammatory activity. We found that it is depleted in patients with colorectal cancer (CRC) from multiple cohorts. Here, we examined the immunomodulatory effect of _C…
Presenter
Speakers
The Chinese University of Hong Kong - DateMay 20, 2024The gut microbiota is closely related to cancer patient response to immune checkpoint inhibitors (ICI). However, there are inconsistencies in species affecting ICI efficacy, whilst the role of non-bacterial microbes in immunotherapy remains elusive…
Presenter
Speakers
The Chinese University of Hong Kong - DateMay 18, 2024BACKGROUND: The roles of probiotics in inhibiting gastric cancer (GC) and effecting _H. pylori_ infection are largely unclear. We identified _Faecalibacterium prausnitzii_ is depleted in GC. We aimed to evaluate the antitumorigenic function and molecular mechanism of _F…
Presenter
Speakers
The Chinese University of Hong Kong - DateMay 18, 2024TUMOR PROMOTING ROLE OF EPIPLOIC ADIPOSE TISSUE IN COLON OF OBESE INDIVIDUALS IS MEDIATED VIA LIPID DROPLETS ASSOCIATED ADIPOSE TRIGLYCERIDE LIPASE (ATGL)
Moderators
Tufts Medical CenterMayo ClinicSpeakers